An inhaled inducible nitric oxide synthase inhibitor reduces damage of Candida-induced acute lung injury

Biomedical Research

Volumn 28, Issue 2, 2007, Pages 91-99

  Ohsugi, Shuji ^a   Iwasaki, Yoshinobu ^a   Takemura, Yoshizumi ^a,b   Nagata, Kazuhiro ^a   Harada, Hidehiko ^a   Yokomura, Ichiro ^a   Hosogi, Shigekuni ^a   Yuba, Tatsuya ^a   Niisato, Naomi ^a   Miyazaki, Hiroaki ^a   Matsubara, Hiroaki ^a   Fushiki, Shinji ^a   Marunaka, Yoshinori ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 7 CHLORO 3 IMINO 5 METHYL 2 AZABICYCLO[4.1.0]HEPTANE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; NITRATE; NITRITE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDEMIA; CONTROLLED STUDY; DRUG EFFICACY; ENZYME INHIBITION; GENE EXPRESSION; LUNG LAVAGE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION;

ADMINISTRATION, INHALATION; AMIDINES; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CANDIDIASIS; ENZYME INHIBITORS; HETEROCYCLIC COMPOUNDS, 2-RING; HUMANS; LUNG; LUNG DISEASES; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PEROXYNITROUS ACID;

CANDIDA; CANDIDA ALBICANS; MUS;

EID: 34249811770     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.28.91     Document Type: Article

References (48)

1. Allendoerfer R, Magee DM, Smith JG, Bonewald L and Graybill JR (1993) Induction of tumor necrosis factor-α in murine Candida albicans infection. J Inf Dis 167, 1168-1172.
2. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, Edwards JR, Tolson J, Henderson T and Martone WJ (1991) Secular trends in nosocomial primary bloodstream infections in the United States. 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 91 (Suppl 3B), 86-89.
3. Beckman JS, Ischiropoulos H, Zhu L, van der Woerd M, Smith C, Chen J, Harrison J, Martin JC and Tsai M (1992) Kinetics of superoxide dismutase and iron catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys 298, 439-445.
4. Brigham KL and Meyrick B (1983) Endotoxin and lung injury. Am Review Respir Dis 133, 913-927.
5. Booke M, Hinder F, Traber LD, McGuire R and Traber DL (1995) S-Ethylisothiourea, a nonamino acid inhibitor of nitric oxide synthase, reverses septic vaodilation in sheep. Shock 4, 274-281.
6. Chen JX, Berry LC, Tanner M, Chang M, Myers RP and Meyrick B (2001) Nitric oxide donors regulate nitric oxide synthase in bovine pulmonary artery endothelium. J Cell Physiol 186, 116-123.
7. Di Massimo C, Scarpelli P, Di Lorenzo N, Caimi G, di Orio F and Ciancarelli MG (2006) Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age. Life Sci 78, 1163-1167.
8. Dinarello CA and Wolff SM (1993) The role of interleukin-1 in disease. New Engl J Med 328, 106-113.
9. Feinstein DL, Galea E, Aquino DA, Li GC, Xu H and Reis DJ (1996) Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFκB activation. J Biol Chem 27, 17724-17732.
10. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G and Dunagan WC (1992) Candidemia in a tertiary care hospital: epidemiology, risk factors and predictors of mortality. Clin Inf Dis 15, 414-421.
11. Fridkin SK and Jarvis ATR (1996) Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 9, 499-511.
12. Geller DA, Nussler AK, Di Silvio M, Lowenstein CJ, Shapiro RA, Wang SC, Simmons RL and Billiar TR (1993) Cytokine, endotoxin, and glucocorticoides regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 90, 522-526.
13. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Laichalk LL, McGillicuddy DC, and Standiford TJ (1996) Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Inf Dis 173, 159-165.
14. Gunnett CA, Heistad DD, Loihl A and Faraci FM (2000) Tumor necrosis factor-alpha impairs contraction but not relaxation in carotid arteries from iNOS-deficient mice. Am J Physiol Reg Integ Comp Physiol 279, R1558-RI564.
15. Gupta S, Feng L, Yoshimura T, Redick J, Fu SM and Rose Jr CE (1996) Intra-alveolar macrophage-inflammatory peptide 2 induces rapid neutrophil localization in the lung. Am J Respir Cell Mol Biol 15, 656-663.
16. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, Bousquet J, Godard P, Holgate S and Polak JM (1993) Induction of nitric oxide synthase in asthma. Lancet 342, 1510-1513.
17. Hashimoto M, Ito T, Fukumitsu H, Nomoto H, Furukawa Y and Furukawa S (2005) Stimulation of production of glial cell line-derived neurotrophic factor and nitric oxide by lipopolysaccharide with different dose-responsiveness in cultured rat macrophages. Biomed Res 26, 223-229.
18. Heiss LN, Lancaster Jr JR, Corbett JA and Goldman WE (1994) Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc Natl Acad Sci USA 91, 267-270.
19. Ischiropoulos H, Zhu L and Beckman JS (1992) Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 298, 446-451.
20. Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Inf Dis 20, 1526-1530.
21. Khanduja KL, Sohi KK, Pathak CM and Kaushik G (2006) Nimesulide inhibits lipopolysaccharide-induced production of superoxide anions and nitric oxide and iNOS expression in alveolar macrophages. Life Sci 78, 1662-1669.
22. Klein JJ and Watanakunokorn C (1979) Hospital-acquired fungemia. Its natural course and clinical significance. Am J Med 67, 51-58.
23. Kristof AS, Goldberg P, Laubach V and Hussain SN (1998) Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 158, 1883-1889.
24. Kroncke KD, Fehsel K and Kolb-Bachofen V (1998) Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113, 147-156.
25. Kubota Y, Iwasaki Y, Harada H, Yokomura I, Ueda M, Hashimoto S and Nakagawa M (2001) Role of alveolar macrophages in Candida-induced acute lung injury. Clin Diag Lab Immunol 8, 1258-1262.
26. Lechner AJ, Ryerse JS and Matuschak GM (1993) Acute lung injury during bacterial or fungal sepsis. Microscopy Res Tech 26, 444-456.
27. Li W, Tsubouchi R, Qiao S, Haneda M, Murakami K and Yoshino M (2006) Inhibitory action of eugenol compounds on the production of nitric oxide in RAW264.7 macrophages. Biomed Res 27, 69-74.
28. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Synder SH, Russell SW and Murphy WJ (1993) Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA, 90, 9730-9734.
29. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H and Mudgett IS (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81, 641-650.
30. MacNaul KL and Hutchinson NI (1993) Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun 196, 1330-1334.
31. Marcinkiewicz J, Grabowska A and Chain B (1995) Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur J Immunol 25, 947-951.
32. Matuschak GM, Klein CA, Tredway TL, Schilly DR and Lechner AJ (1993) TNF-α and cyclooxygenase metabolites do not modulate C. albicans septic shock with disseminated candidasis. J Appl Physiol 74, 2432-2442.
33. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM and Wilmore DW (1988) Detection of circulating tumor necrosis factor after endotoxin administration. New Engl J Med 318, 1481-1486.
34. Mikawa K, Nishina K, Takao Y and Obara H (2003) ONO-1714, a nitric oxide synthase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits. Anesth Analg 97, 1751-1755.
35. Mulligan MS, Hevel JM, Marletta MA and Ward PA (1991) Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA 88, 6338-6342.
36. Naka M, Nanbu T, Kobayashi K, Kamanaka Y, Komeno M, Yanase R, Fukutomi T, Fujimura S, Seo HG, Fujiwara, N, Ohuchida S, Suzuki K, Kondo K and Taniguchi N (2000) A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative. Biochem Biophys Res Commun 270, 663-667.
37. Okamoto I, Abe M, Shibata K, Shimizu N, Sakata N, Katsuragi T and Tanaka K (2000) Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am J Respir Crit Care Med 162, 716-722.
38. Okusawa S, Gelfand JA, Ikejima T, Connolly RA and Dinarello, CA (1988) Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 81, 1162-1172.
39. Stuehr DJ, Marletta MA (1987) Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-γ. J Immunol 139, 518-525.
40. Szabo C, Mitchell JA, Thiemermann C and Vane JR (1993) Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 108, 786-792.
41. Szabo C, Southan GJ and Thiemermann C (1994) Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91 12472-12476.
42. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S and Liew FY (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411.
43. Wey SB, Mori M, Pfaller MA, Woolson RF and Wenzel RP (1988) Hospital acquired candidemia: the attributable mortality and excess length of stay. Arch Intl Med 148, 2642-2645.
44. Wey SB, Mori M, Pfaller MA, Woolson RF and Wenzel RP (1989) Risk factors for hospital-acquired candidemia: a matched case-control study. Arch Intl Med 149, 2349-2353.
45. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T and Nathan C (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256, 225-228.
46. Xie QW, Kashiwabara Y and Nathan C (1994) Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269, 4705-4708.
47. Xie QW, Whisnant R and Nathan C (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 177, 1779-1784.
48. Yuhanna IS, MacRitchie AN, Lantin-Hermoso RL, Wells LB and Shaul PW (1999) Nitric oxide (NO) upregulates NO synthase expression in fetal intrapulmonary artery endothelial cells. Am J Respir Cell Mol Biol 21, 629-636.